ZR202-CoV

ZR202-CoV · Shanghai Zerun Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZR202-CoV, covering 2023-04-20 to 2023-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults. [Phase 1, Phase 2]

See pricing